메뉴 건너뛰기
Journal of Sichuan University (Medical Science)
Volumn 40, Issue 6, 2009, Pages 1066-1070
The activity of platelet activating factor acetylhydrolase and its metabolic profile in patients with polycystic ovary syndrome
Author keywords

Insulin resistance; Lipid profile; Platelet activating factor acetylhydrolase; Polycystic ovary syndrome
Indexed keywords

EID: 73049117520     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (2)
References (13)
  • 1
    • 39049121322 scopus 로고    scopus 로고
    • A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: A case-control study
    • Valkenburg O, Steegers-Theunissen RP, Smedts HP, et al. A more atherogenic serum lipoprotein profile is present in women with polycystic ovary syndrome: a case-control study. J Clin Endocrinol Metab, 2008;93(2):470-476.
    • (2008) J Clin Endocrinol Metab , vol.93 , Issue.2 , pp. 470-476
    • Valkenburg, O.1    Steegers-Theunissen, R.P.2    Smedts, H.P.3
  • 2
    • 73049094348 scopus 로고    scopus 로고
    • Chinese source
    • Chinese source
  • 3
    • 33748708041 scopus 로고    scopus 로고
    • Inflammatory and endothelial markers in women with polycystic ovary syndrome
    • Diamanti-Kandarakis E, Alexandraki K, Piperi C, et al. Inflammatory and endothelial markers in women with polycystic ovary syndrome. Eur J Clin Invest, 2006;36(10):691-697.
    • (2006) Eur J Clin Invest , vol.36 , Issue.10 , pp. 691-697
    • Diamanti-Kandarakis, E.1    Alexandraki, K.2    Piperi, C.3
  • 4
    • 33645851024 scopus 로고    scopus 로고
    • The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients
    • Palacio JR, Iborra A, Ulcova-Gallova Z, et al. The presence of antibodies to oxidative modified proteins in serum from polycystic ovary syndrome patients. Clin Exp Immunol, 2006;144(2):217-222.
    • (2006) Clin Exp Immunol , vol.144 , Issue.2 , pp. 217-222
    • Palacio, J.R.1    Iborra, A.2    Ulcova-Gallova, Z.3
  • 5
    • 36849023426 scopus 로고    scopus 로고
    • Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis
    • Shroff R, Kerchner A, Maifeld M, et al. Young obese women with polycystic ovary syndrome have evidence of early coronary atherosclerosis. J Clin Endocrinol Metab, 2007;92(12):4609-4614.
    • (2007) J Clin Endocrinol Metab , vol.92 , Issue.12 , pp. 4609-4614
    • Shroff, R.1    Kerchner, A.2    Maifeld, M.3
  • 6
    • 18844421079 scopus 로고    scopus 로고
    • Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase
    • Castro Faria Neto HC, Stafforini DM, Prescott SM, et al. Regulating inflammation through the anti-inflammatory enzyme platelet-activating factor-acetylhydrolase. Mem Inst Oswaldo Cruz, 2005;100 (Suppl 1):83-91.
    • (2005) Mem Inst Oswaldo Cruz , vol.100 , Issue.SUPPL. 1 , pp. 83-91
    • Castro1    Faria Neto, H.C.2    Stafforini, D.M.3    Prescott, S.M.4
  • 7
    • 2542460047 scopus 로고    scopus 로고
    • The oxidation hypothesis of atherogenesis: The role of oxidized phospholipids and HDL
    • Navab M, Ananthramaiah GM, Reddy ST, et al. The oxidation hypothesis of atherogenesis: the role of oxidized phospholipids and HDL. J Lipid Res, 2004;45(6):993-1007.
    • (2004) J Lipid Res , vol.45 , Issue.6 , pp. 993-1007
    • Navab, M.1    Ananthramaiah, G.M.2    Reddy, S.T.3
  • 8
    • 33750943178 scopus 로고    scopus 로고
    • Clinical aspects of plasma platelet-activating factor-acetylhydrolase
    • Karasawa K. Clinical aspects of plasma platelet-activating factor-acetylhydrolase. Biochim Biophys Acta, 2006;1761(11):1359-1372.
    • (2006) Biochim Biophys Acta , vol.1761 , Issue.11 , pp. 1359-1372
    • Karasawa, K.1
  • 9
    • 26844557382 scopus 로고    scopus 로고
    • Serum lipid levels and factors affecting atherogenic index in Japanese children
    • Takasaki Y. Serum lipid levels and factors affecting atherogenic index in Japanese children. J Physiol Anthropol Appl Human Sci, 2005;24(4):511-515.
    • (2005) J Physiol Anthropol Appl Human Sci , vol.24 , Issue.4 , pp. 511-515
    • Takasaki, Y.1
  • 10
    • 33646432490 scopus 로고    scopus 로고
    • Modulating effects of cholesterol feeding and simvastatin treatment on plateletactivating factor acetylhydrolase activity and lysophosphatidylcholine concentration
    • Zhang B, Fan P, Shimoji E, et al. Modulating effects of cholesterol feeding and simvastatin treatment on plateletactivating factor acetylhydrolase activity and lysophosphatidylcholine concentration. Atherosclerosis, 2006;186(2):291-301.
    • (2006) Atherosclerosis , vol.186 , Issue.2 , pp. 291-301
    • Zhang, B.1    Fan, P.2    Shimoji, E.3
  • 11
    • 0042125177 scopus 로고    scopus 로고
    • Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease
    • Caslake MJ, Packard CJ. Lipoprotein-associated phospholipase A2 (platelet-activating factor acetylhydrolase) and cardiovascular disease. Curr Opin Lìpidol, 2003;14(4):347-352.
    • (2003) Curr Opin Lìpidol , vol.14 , Issue.4 , pp. 347-352
    • Caslake, M.J.1    Packard, C.J.2
  • 12
    • 17344394888 scopus 로고    scopus 로고
    • Plateletactivating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction
    • Benitez S, Sanchez-Quesada JL, Ribas V, et al. Plateletactivating factor acetylhydrolase is mainly associated with electronegative low-density lipoprotein subfraction. Circulation, 2003;108(1):92-96.
    • (2003) Circulation , vol.108 , Issue.1 , pp. 92-96
    • Benitez, S.1    Sanchez-Quesada, J.L.2    Ribas, V.3
  • 13
    • 73049095860 scopus 로고    scopus 로고
    • Chinese source
    • Chinese source

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.